Loading company…
Rhinostics makes nasal swab collection kits designed for automated laboratory processing.
Founded in 2020 in Massachusetts, US, Rhinostics develops nasal swab collection kits with a combined cap and swab and a barcode for automated vial processing. Its system supports sample collection, accessioning, and cap removal for high-throughput testing. The RHINOsticTM product is an FDA-approved Class I exempt medical device, and the company raised seed funding in December 2020 followed by Series A funding in March 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in